C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01)
Patent
CA 2740242
Methods for determining whether a patient is at increased risk of developing wet AMD or whether a patient has an increased likelihood of benefiting from treatment with a high-affinity anti- VEGF antibody.
L'invention porte sur des procédés pour déterminer si un patient présente un risque accru de développer une dégénérescence maculaire liée à l'âge humide ou si un patient a une probabilité accrue de bénéficier d'un traitement par un anticorps anti-VEGF à haute affinité.
Behrens Timothy W.
Graham Robert R.
Ianchulev Tsontcho
Shapiro Howard
Genentech Inc.
Smart & Biggar
LandOfFree
Genetic polymorphisms in age-related macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic polymorphisms in age-related macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic polymorphisms in age-related macular degeneration will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1798301